Increasing pet ownership and spending on pet healthcare services drive the demand for veterinary intravenous solutions.
Growing awareness about the importance of preventive care and early diagnosis in animals boosts the adoption of veterinary intravenous solutions.
Rising prevalence of chronic diseases and conditions in animals propels the demand for advanced healthcare solutions, including intravenous therapies.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Animal Type, Indication, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Merck & Co.,, Dechra Veterinary Products, Sypharma, Animalcare, B. Braun SE, Woods Consulting, LLC, Baxter, Fresenius Kabi |
Stringent regulatory requirements and guidelines for the approval and usage of veterinary intravenous solutions limit market growth.
High cost associated with the development and manufacturing of veterinary intravenous solutions restrains market expansion.